Walleye Capital’s Evolent Health EVH Stock Holding History

Walleye Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,800	Closed	-$51.2K	–	4563
2025 Q4	$51.2K	Sell	12,800 -9,800	-43%	-$54.5K	﹤0.01%	4072
2025 Q3	$191K	Buy	+22,600	New	+$219K	﹤0.01%	3345
2025 Q2	–	Sell	-6,500	Closed	-$61.6K	–	4644
2025 Q1	$61.6K	Sell	6,500 -10,000	-61%	-$101K	﹤0.01%	3785
2024 Q4	$186K	Sell	16,500 -24,800	-60%	-$436K	﹤0.01%	3814
2024 Q3	$1.17M	Buy	+41,300	New	+$1.06M	﹤0.01%	2489
2023 Q2	–	Sell	-5,400	Closed	-$175K	–	4471
2023 Q1	$175K	Buy	+5,400	New	+$171K	﹤0.01%	2565
2019 Q2	–	Sell	-23,200	Closed	-$292K	–	1823
2019 Q1	$292K	Buy	+23,200	New	+$367K	0.05%	613

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's EVH Position: Q1 2026 in Review

Walleye Capital reduced its Evolent Health (EVH) stake by 2% in Q1 2026, selling an estimated $8.83K and leaving 135,948 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Walleye Capital first reported a position in EVH in Q2 2019 and has held it in 11 quarters since. The position peaked at $7.29M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Walleye Capital held 135,948 shares of Evolent Health worth $310K as of Q1 2026.
Walleye Capital sold 2,784 Evolent Health shares in Q1 2026, an estimated $8.83K.
Evolent Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3040 holding.
Walleye Capital first reported a position in Evolent Health in Q2 2019 and has held it in 11 quarters since.
Walleye Capital's Evolent Health position peaked at $7.29M in Q2 2025.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.